From Steatosis to Fibrosis and Beyond – What Non-Invasive Imaging Can Do in MASLD/MASH
Time: 4:00 pm
day: Conf Day 1 EOD
Details:
- Understanding the complexity of MASH/MASLD including its downstream consequences
- New advances in clinical non-invasive imaging of fibrosis and cirrhosis
- How insights from multiple biomarkers can shape decision making in drug development
